$21.07
-1.11[-5.00%]
At close: Mar 28
$21.07
0[0.00%]
After Hours: 4:00PM EDT
Regenxbio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Regenxbio using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | PM | RGNX | Q1 | -$1.53 | -$1.27 | — | — | $19.14M | $24.03M | — | — | Get Alert |
02/27/2024 | PM | RGNX | Q4 | -$1.38 | -$1.27 | -$1.43 | -12.60% | $31.34M | $34.00M | $22.21M | -34.67% | Get Alert |
11/08/2023 | PM | RGNX | Q3 | -$1.75 | -$1.49 | -$1.41 | 5.37% | $26.51M | $27.19M | $28.91M | 6.34% | Get Alert |
08/02/2023 | PM | RGNX | Q2 | -$1.58 | -$1.26 | -$1.66 | -31.75% | $32.65M | $39.83M | $19.98M | -49.84% | Get Alert |
05/03/2023 | PM | RGNX | Q1 | -$1.79 | -$1.54 | -$1.53 | 0.65% | $22.22M | $30.60M | $19.14M | -37.46% | Get Alert |
02/28/2023 | PM | RGNX | Q4 | $6.67 | -$1.23 | -$1.38 | -12.20% | $398.65M | $37.45M | $31.34M | -16.30% | Get Alert |
11/03/2022 | AM | RGNX | Q3 | -$1.37 | -$1.46 | -$1.75 | -19.86% | $30.77M | $30.81M | $26.51M | -13.95% | Get Alert |
08/03/2022 | PM | RGNX | Q2 | -$1.36 | -$1.53 | -$1.58 | -3.27% | $22.04M | $26.79M | $32.65M | 21.87% | Get Alert |
05/04/2022 | PM | RGNX | Q1 | -$1.20 | -$1.32 | -$1.58 | -19.70% | $18.88M | $29.21M | $22.22M | -23.94% | Get Alert |
03/01/2022 | PM | RGNX | Q4 | -$1.24 | $4.71 | $6.67 | 41.61% | $21.45M | $271.74M | $398.65M | 46.70% | Get Alert |
11/02/2021 | PM | RGNX | Q3 | $0.23 | -$1.08 | -$1.37 | -26.85% | $98.91M | $41.46M | $30.77M | -25.78% | Get Alert |
08/09/2021 | PM | RGNX | Q2 | -$0.91 | -$1.12 | -$1.36 | -21.43% | $16.57M | $29.02M | $22.04M | -24.07% | Get Alert |
05/05/2021 | PM | RGNX | Q1 | -$1.08 | -$1.28 | -$1.20 | 6.25% | $17.64M | $23.23M | $18.88M | -18.71% | Get Alert |
03/01/2021 | PM | RGNX | Q4 | -$0.72 | -$0.43 | -$1.24 | -188.37% | $11.77M | $61.50M | $21.45M | -65.13% | Get Alert |
11/04/2020 | PM | RGNX | Q3 | -$0.94 | -$1.01 | $0.23 | 122.77% | $14.70M | $21.37M | $98.91M | 362.85% | Get Alert |
08/06/2020 | PM | RGNX | Q2 | -$0.04 | -$0.94 | -$0.91 | 3.19% | $7.88M | $22.07M | $16.57M | -24.94% | Get Alert |
05/07/2020 | PM | RGNX | Q1 | -$0.89 | -$0.87 | -$1.08 | -24.14% | $884.00K | $18.45M | $17.64M | -4.37% | Get Alert |
02/26/2020 | PM | RGNX | Q4 | $0.11 | -$0.44 | -$0.72 | -63.64% | $40.78M | — | $11.77M | — | Get Alert |
11/05/2019 | PM | RGNX | Q3 | -$0.56 | -$0.72 | -$0.94 | -30.56% | $5.31M | $9.74M | $14.70M | 50.92% | Get Alert |
Regenxbio (RGNX) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $-1.43, which missed the estimate of $-1.27.
The Actual Revenue was $22.2M, which missed the estimate of $34M.
Browse earnings estimates, EPS, and revenue on all stocks.